Development of breast cancer mortality considering the implementation of mammography screening programs – a comparison of western European countries

Iwamoto, Yukio; Kaucher, Simone; Lorenz, Eva; Bärnighausen, Till; Winkler, Volker

doi:10.1186/s12889-019-7166-6

Table 1 MSPs in western European countries with more than 4.5 million inhabitants [7, 8, 10,11,12,13,14,15]

From: Development of breast cancer mortality considering the implementation of mammography screening programs – a comparison of western European countries

Country	Implementation Period^a	Age range of women eligible for screening	Participation rate	Years for analysis
Austria^b	2014	50–69	–	2004–2017
Belgium^c	2001	50–69	2005: 38% [7]	1991–2015
Denmark^d	2007–2010	50–69	2010: 73% [12]	1997–2015
Finland^e	1987	50–69	2010: 85% [12]	1980–2015
France^f	1989–2004	50–74	2010: 52% [12]	1980–2015
Germany	2005–2009	50–69	2014: 54% [14]	1995–2015
Italy	2002–2007	50–69	2010: 61% [12]	1992–2015
Netherlands^g	1988–1997	50–75	2010: 81% [12]	1980–2016
Norway	1996–2004	50–69	2010: 76% [12]	1986–2016
Portugal^h	1990–1999	45–69	2010: 63/58% [12]	1989–2016
Spainⁱ	1990–2003	50–69	2015: 75% [13]	1980–2016
Sweden^j	1986–1996	40–74	2010: 70% [12]	1980–2016
Switzerland^k	1999–2004	50–70	2012: 46% [16]	1989–2015
United Kingdom^l	1988–1995	50–70	2010: 73% [12]	1980–2015

^aThe implementation period is defined as the year when the roll-out of a national MSP began until the year in which a 100% geographical national coverage was achieved. The degree of completeness, measurable e.g. by % coverage by invitation, as well as pace and strategy of roll-out varies between countries
^bIn Austria, an opportunistic screening without an invitation mechanism or dedicated mammography screening centers was introduced in 1974, but an organized MSP was only introduced in 2014
^cIn Belgium, the participation rate for 2005 is just for the province Flanders
^dIn Denmark, a population-based screening program started in 1991 in Copenhagen and in 1993 in the region of Funen. In 2007, nationwide MSP was rolled out
^eIn Finland, in some regions, the upper limit of invitation is 59, while in others 69
^fIn France, partial regional screening was introduced in 1989, followed by a partial national screening covering some parts of France from 1994. The MSP was initially planned for women aged 50–69 and the age-range was then extended to 50–74 [17]
^gIn the Netherlands, an MSP for women aged 50–69 was implemented from 1987 to 1997 and extended to age 74 from 1998 to 2001 [18]
^hIn Portugal, an MSP was launched in 1990 in the northern Central Region and in 1997 in the southern Alentejo Region. The participation rates are therefore mentioned separately for these regions (63% in Central, 58% in Alentejo)
ⁱIn Spain, the model of MSPs varies throughout the different states regarding screened age groups and initiation years. In most parts of the country, an organized MSP was introduced during 1990–2003 targeting 50–69-year-old women. Some parts start screening already at age 45, other parts stop screening at 65
^jIn Sweden, pilot projects started in 1982 and screening was recommended for women aged 50–69. Later the screened age range was extended
^kIn Switzerland, the geographical coverage for organized MSPs in 2012 was 37%, and was still at 56% in 2015 [16]. The coverage by invitation within the target population, however, was at 93% (2012) and 99% (2015) with participation rates of 46% (2012) and 41% (2015) respectively
^lIn the United Kingdom, the screened age group was 50–64, from 1988 to 2001 [8]

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Public Health

Contact us